Mail-order drug delivery surges amid pandemic

Patients are increasingly opting for prescription drug delivery services instead of in-person pharmacy visits during the pandemic, according to The Wall Street Journal

The fear of contracting COVID-19 keeps many Americans from venturing outside their homes, especially if they can avoid it. Drug delivery companies and the now widespread availability of delivery options offered by retail and locally owned pharmacies is making patients feel they have a safer option.

Mail-order prescriptions increased 21 percent from last year during the last week of March, now taking up 5.8 percent of the total prescription drug market share. Retail pharmacy giant CVS reported a 10-fold increase in prescription deliveries after eliminating fees in early March, The Wall Street Journal reported.

This trend is not expected to go away after the pandemic. This is especially true among younger patients, who have fewer prescriptions and are used to purchasing online.

More articles on pharmacy:
Drugmakers forced to reshape sales strategy amid pandemic
NIH to test remdesivir in combo with Eli Lilly arthritis drug
Regeneron says its COVID-19 antibody drug could be ready by fall

 

NIH to test remdesivir in combo with Eli Lilly arthritis drug

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Content

Featured Webinars

Featured Whitepapers